Godala, M.; Gaszyńska, E.; Walczak, K.; Małecka-Wojciesko, E.
Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. J. Clin. Med. 2023, 12, 5956.
https://doi.org/10.3390/jcm12185956
AMA Style
Godala M, Gaszyńska E, Walczak K, Małecka-Wojciesko E.
Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine. 2023; 12(18):5956.
https://doi.org/10.3390/jcm12185956
Chicago/Turabian Style
Godala, Małgorzata, Ewelina Gaszyńska, Konrad Walczak, and Ewa Małecka-Wojciesko.
2023. "Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease" Journal of Clinical Medicine 12, no. 18: 5956.
https://doi.org/10.3390/jcm12185956
APA Style
Godala, M., Gaszyńska, E., Walczak, K., & Małecka-Wojciesko, E.
(2023). Role of Serum Interleukin-6, Interleukin-1β and Interleukin-10 in Assessment of Disease Activity and Nutritional Status in Patients with Inflammatory Bowel Disease. Journal of Clinical Medicine, 12(18), 5956.
https://doi.org/10.3390/jcm12185956